1887

Abstract

is a Gram-negative bacteria associated with periodontal disease in humans. Cases of extra-oral manifestations of infection are rare with only six reported cases of extra-oral infection including this report that have been identified in the current literature. Molecular methods are generally used to identify while optimal antibiotic choice and duration to treat extra-oral infections for this pathogen is unknown.

A 63-year-old male with a background history of alcoholic pancreatitis presented with fever and malaise who was found to have radiological intra-abdominal collections. Drainage of these collections identified via matrix-assisted laser desorption/ionisation time of flight (MALDI-TOF) mass spectrometry with high probability and identification further confirmed by whole-genome sequencing. Antibiotic susceptibility testing to erythromycin and ciprofloxacin of was performed using E-test diffusion methods along with investigation for the presence of resistance genes. The patient was treated with intravenous piperacillin-tazobactam followed by ciprofloxacin for 4 weeks total with good clinical recovery.

Extra-oral manifestations with the pathogen are rare with few cases described in the literature. There is minimal data on susceptibility patterns, optimal antibiotic treatment and duration. Treatment of extraintestinal infections in humans should encompass both adequate source control and antibiotic therapy.

Loading

Article metrics loading...

/content/journal/acmi/10.1099/acmi.0.000227
2021-04-21
2021-05-14
Loading full text...

Full text loading...

/deliver/fulltext/acmi/3/4/acmi000227.html?itemId=/content/journal/acmi/10.1099/acmi.0.000227&mimeType=html&fmt=ahah

References

  1. Costa D, Iraola G. Pathogenomics of emerging Campylobacter species. Clin Microbiol Rev 2019; 32:1–24 [CrossRef][PubMed]
    [Google Scholar]
  2. Man SM. The clinical importance of emerging Campylobacter species. Nat Rev Gastroenterol Hepatol 2011; 8:669–685 [CrossRef][PubMed]
    [Google Scholar]
  3. Liu F, Ma R, Wang Y, Zhang L. The clinical importance of Campylobacter concisus and other human hosted Campylobacter species. Front Cell Infect Microbiol 2018; 8:1–22 [CrossRef]
    [Google Scholar]
  4. Tanner ACR, Listgarten MA, Ebersole JL. Wolinella curva sp. nov.: "Vibrio succinogenes" of human origin. Int J Syst Bacteriol 1984; 34:275–282 [CrossRef]
    [Google Scholar]
  5. Brondz I, Olsen I. Multivariate analyses of cellular fatty acids in Bacteroides, Prevotella, Porphyromonas, Wolinella, and Campylobacter spp. J Clin Microbiol 1991; 29:183–189 [CrossRef][PubMed]
    [Google Scholar]
  6. Vandamme P, Falsen E, Rossau R, Hoste B, Segers P et al. Revision of Campylobacter, Helicobacter, and Wolinella taxonomy: emendation of generic descriptions and proposal of Arcobacter gen. nov. Int J Syst Bacteriol 1991; 41:88–103 [CrossRef][PubMed]
    [Google Scholar]
  7. Abbott SL, Waddington M, Lindquist D et al. Associated with sporadic episodes of bloody gastroenteritis and brainerd’s diarrhea. J Clin Microbiol 2005; 43:585–588
    [Google Scholar]
  8. Wetsch NM, Somani K, Tyrrell GJ, Gebhart C, Bailey RJ et al. Campylobacter curvus-associated hepatic abscesses: a case report. J Clin Microbiol 2006; 44:1909–1911 [CrossRef][PubMed]
    [Google Scholar]
  9. Han XY, Tarrand JJ, Rice DC. Oral Campylobacter species involved in extraoral abscess: a report of three cases. J Clin Microbiol 2005; 43:2513–2515 [CrossRef][PubMed]
    [Google Scholar]
  10. Horio Y, Shiraishi Y, Watanabe N, Inoue S, Imanishi T et al. Empyema associated with Campylobacter curvus infection. Respirol Case Rep 2017; 5:e00234–00236 [CrossRef][PubMed]
    [Google Scholar]
  11. Mendz GL, Petersen R, Quinlivan JA, Kaakoush NO. Potential involvement of Campylobacter curvus and Haemophilus parainfluenzae in preterm birth. BMJ Case Rep 2014; 2014:1–4 [CrossRef][PubMed]
    [Google Scholar]
  12. Seemann T. Prokka: rapid prokaryotic genome annotation. Bioinformatics 2014; 30:2068–2069 [CrossRef][PubMed]
    [Google Scholar]
  13. Kaakoush NO, Castaño-Rodríguez N, Mitchell HM, Man SM. Global epidemiology of campylobacter infection. Clin Microbiol Rev 2015; 28:687–720 [CrossRef][PubMed]
    [Google Scholar]
  14. Lastovica AJ. Emerging Campylobacter spp.: the tip of the iceberg. Clin Microbiol Newsl 2006; 28:49–56 [CrossRef]
    [Google Scholar]
  15. Maher M, Finnegan C, Collins E, Ward B, Carroll C et al. Evaluation of culture methods and a DNA probe-based PCR assay for detection of Campylobacter species in clinical specimens of feces. J Clin Microbiol 2003; 41:2980–2986 [CrossRef][PubMed]
    [Google Scholar]
  16. Mukhopadhya I, Thomson JM, Hansen R, Berry SH, El-Omar EM et al. Detection of Campylobacter concisus and other Campylobacter species in colonic biopsies from adults with ulcerative colitis. PLoS One 2011; 6:e21490 [CrossRef][PubMed]
    [Google Scholar]
  17. Lastovica AJ, le Roux E. Efficient isolation of campylobacteria from stools. J Clin Microbiol 2000; 38:2798–2799[PubMed]
    [Google Scholar]
  18. de Vries JJC, Arents NLA, Manson WL. Campylobacter species isolated from extra-oro-intestinal abscesses: a report of four cases and literature review. Eur J Clin Microbiol Infect Dis 2008; 27:1119–1123 [CrossRef][PubMed]
    [Google Scholar]
  19. Martiny D, Dediste A, Debruyne L, Vlaes L, Haddou NB et al. Accuracy of the API Campy system, the Vitek 2 Neisseria-Haemophilus card and matrix-assisted laser desorption ionization time-of-flight mass spectrometry for the identification of Campylobacter and related organisms. Clin Microbiol Infect 2011; 17:1001–1006 [CrossRef][PubMed]
    [Google Scholar]
  20. Wieczorek K, Osek J. Antimicrobial resistance mechanisms among Campylobacter . Biomed Res Int 2013; 2013:112 [CrossRef]
    [Google Scholar]
  21. Tajada P, Gomez-Graces JL, Alós JI, Balas D, Cogollos R. Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli to 12 β-lactam agents and combinations with β-lactamase inhibitors. Antimicrob Agents Chemother 1996; 40:1924–1925 [CrossRef][PubMed]
    [Google Scholar]
  22. The European Committee on Antimicrobial Susceptibility Testing Breakpoint tables for interpretation of MICs and zone diameters, version 10.0; 2020
  23. Xia Q, Muraoka WT, Shen Z, Sahin O, Wang H et al. Adaptive mechanisms of Campylobacter jejuni to erythromycin treatment. BMC Microbiol 2013; 13:1 [CrossRef]
    [Google Scholar]
  24. Vandenberg O, Houf K, Douat N, Vlaes L, Retore P et al. Antimicrobial susceptibility of clinical isolates of non-jejuni/coli campylobacters and arcobacters from Belgium. J Antimicrob Chemother 2006; 57:908–913 [CrossRef][PubMed]
    [Google Scholar]
  25. Gunther NW, Chen C-Y. The biofilm forming potential of bacterial species in the genus Campylobacter . Food Microbiol 2009; 26:44–51 [CrossRef][PubMed]
    [Google Scholar]
  26. Bergy D, Holt J. Bergey’s Manual of Determinative Bacteriology, 9th ed. Philadelphia: Williams & Wilkins: Lippincott; 2000
    [Google Scholar]
  27. Etoh Y, Dewhirst FE, Paster BJ, Yamamoto A, Goto N. Campylobacter showae sp. nov., isolated from the human oral cavity. Int J Syst Bacteriol 1993; 43:631–639 [CrossRef][PubMed]
    [Google Scholar]
  28. On SL. Taxonomy of Campylobacter, Arcobacter, Helicobacter and related bacteria: current status, future prospects and immediate concerns. Symp Ser Soc Appl Microbiol 2001; 90:1–15 [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/acmi/10.1099/acmi.0.000227
Loading
/content/journal/acmi/10.1099/acmi.0.000227
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error